These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1568046)

  • 1. A case of CREST syndrome with rapidly progressive liver damage.
    Yabe H; Noma K; Tada N; Mochizuki S; Nagano M
    Intern Med; 1992 Jan; 31(1):69-73. PubMed ID: 1568046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
    Lie JT
    Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRST syndrome (calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia) associated with autoimmune hepatitis.
    Ishikawa M; Okada J; Shibuya A; Kondo H
    Intern Med; 1995 Jan; 34(1):6-9. PubMed ID: 7718984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis.
    Shoji I; Takagi T; Kasukawa R
    Intern Med; 1992 Dec; 31(12):1348-55. PubMed ID: 1284406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma.
    Drosos AA; Pennec YL; Elisaf M; Lamour A; Acritidis NC; Jouquan JR; Moutsopoulos HM; Youinou P
    J Rheumatol; 1991 Nov; 18(11):1685-8. PubMed ID: 1787489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcutaneous calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia (CRST syndrome): an association of interest in hepatology (author's transl)].
    Dubois A; Jourdan J; Blotman F; Balmes JL; Janbon F; Bertrand A; Michel H
    Gastroenterol Clin Biol; 1978 Oct; 2(10):805-9. PubMed ID: 729977
    [No Abstract]   [Full Text] [Related]  

  • 7. Coexistence of CREST syndrome and primary biliary cirrhosis. Serological studies of two cases.
    Hirakata M; Akizuki M; Miyachi K; Matsushima H; Okano T; Homma M
    J Rheumatol; 1988 Jul; 15(7):1166-70. PubMed ID: 3172118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodular regenerative hyperplasia of the liver, CREST syndrome and primary biliary cirrhosis: an overlap syndrome?
    McMahon RF; Babbs C; Warnes TW
    Gut; 1989 Oct; 30(10):1430-3. PubMed ID: 2583572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary biliary cirrhosis associated with CRST syndrome (calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia). Effect of cytostatic therapy in a case of our observation].
    Amoroso A; Di Rosa R; Afeltra A; Bolognesi A; Ferri GM; Bonomo L
    Recenti Prog Med; 1988 Apr; 79(4):169-72. PubMed ID: 3393727
    [No Abstract]   [Full Text] [Related]  

  • 10. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ; Kinsella TD
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRST syndrome (calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia).
    Brown AE
    Br J Oral Surg; 1976 Nov; 14(2):137-42. PubMed ID: 1070339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome.
    Reynolds TB; Denison EK; Frankl HD; Lieberman FL; Peters RL
    Am J Med; 1971 Mar; 50(3):302-12. PubMed ID: 5553949
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary sclerosing cholangitis associated with CREST (calcinosis, Raynaud phenomenon, oesophageal dysmotility, sclerodactyly and telangiectasia) in an elderly woman: a case report.
    Powell A; McNeil J
    J Med Case Rep; 2015 Nov; 9():272. PubMed ID: 26607041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD; Smith CD; Senecal JL; Rothfield N
    Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The CREST syndrome associated with the sicca syndrome].
    González Perez JA; Calvo Catala J; Almela Requena JV; González-Cruz Cervellera A; Sospedra Lara EM; Hurtado Vicente MJ
    An Med Interna; 1989 Oct; 6(10):540-2. PubMed ID: 2491051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticentromere antibody: disease specificity and clinical significance.
    Powell FC; Winkelmann RK; Venencie-Lemarchand F; Spurbeck JL; Schroeter AL
    Mayo Clin Proc; 1984 Oct; 59(10):700-6. PubMed ID: 6384675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRST syndrome and nodular transformation of the liver. A case report.
    Lurie B; Novis B; Bank S; Silber W; Botha JB; Marks IN
    Gastroenterology; 1973 Mar; 64(3):457-61. PubMed ID: 4540260
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary biliary cirrhosis with scleroderma, Raynaud's syndrome, telangiectasis and thyroid disease].
    Lichtenstein H; Poupon R; Bodin F; Conte-Marti J; Conte M
    Sem Hop; 1973 Feb; 49(8):555-9. PubMed ID: 4349575
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticentromere antibodies in subjects with no apparent connective tissue disease.
    Lee SL; Tsay GJ; Tsai RT
    Ann Rheum Dis; 1993 Aug; 52(8):586-9. PubMed ID: 8215621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.